Extract of Ginkgo biloba EGb761 facilitates extinction of conditioned fear measured by fear-potentiated startle

Neuropsychopharmacology

Volumn 32, Issue 2, 2007, Pages 332-342

  Yang, Yi Ling ^a   Su, Ya Wen ^b   Ng, Ming Chong ^b   Chao, Po Kuan ^b   Tung, Li Chu ^b   Lu, Kwok Tung ^b  

^a NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

EGb761; Extinction; Extracellular signal regulated kinase; Fear potentiated fear; Ginkgo biloba

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; GINKGO BILOBA EXTRACT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXPERIMENTAL ANIMAL; FEAR; LEARNING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STARTLE REFLEX; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

AMYGDALA; ANIMALS; AVOIDANCE LEARNING; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXTINCTION, PSYCHOLOGICAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEAR; GINKGO BILOBA; MALE; MEMORY DISORDERS; NOOTROPIC AGENTS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION; UP-REGULATION;

EID: 33846261988     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301060     Document Type: Article

References (46)

1. Campeau S, Davis M (1995). Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. J Neurosci 15: 2301-2311.
2. Cassella J, Davis M (1986). The design and calibration of a startle measurement system. Physiol Behav 36: 377-383.
3. Clostre F (2000). Ginkgo biloba extract (EGb761). State of knowledge in the dawn of the year 2000. Ann Pharm Fr 57: 1S8-1S88.
4. Curtis-Prior P, Vere D, Fray P (1999). Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function. J Pharm Pharmacol 51: 535-541.
5. Das A, Shanker G, Nath C, Pal R, Singh S, Singh HA (2002). Comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba: anticholinesterase and cognitive enhancing activities. Pharmacol Biochem Behav 73: 893-900.
6. Davis M (2000). The role of the amygdala in conditioned and unconditioned fear and anxiety. In: Aggleton JP (ed). The Amygdala, Vol 2. Oxford University Press: Oxford, United Kingdom. pp 213-287.
7. Davis M, Falls WA, Gewirtz J (2000). Neural systems involved in fear inhibition: Extinction and conditioned inhibition. In: Myslobodsky M, Weiner I (eds). Contemporary Issues in Modeling Psychopathology. Kluwer Academic Publishers: Boston. pp 113-142.
8. Defeudis FV (1991). Ginkgo biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications. Elsevier: Amsterdam.
9. Diamond BJ, Shifflett C, Feiwel N (2000). Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil 81: 668-678.
10. Drieu K (1986). Preparation et definition de l'extrait de Ginkgo biloba. Presse Med 15: 1455-1457.
11. Enz A, Amstutz R, Boddeke H, Gmelin G, Malanowski J (1993). Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. Prog Brain Res 98: 431-438.
12. Ferry B, Roozendaal B, McGaugh JL (1999). Role of norepinephrine in mediating stress hormone regulation of long-term memory storage: a critical involvement of the amygdala. Biol Psychiatry 46: 1140-1152.
13. Hasenöhrl RU, Nichau CH, Frisch CH, De Souza Silva MA, Huston JP, Mattern CM et al (1996). Anxiolytic-like effect of combined extracts of Zingiber Officinale and Ginkgo biloba in the elevated plus-maze. Pharmacol Biochem Behav 53: 271-275.
14. Hasenöhrl RU, Topic B, Frisch C, Häcker R, Mattern CM, Huston JP (1998). Dissociation between anxiolytic and hypomnestic effects for combined extracts of Zingiber Officinale and Ginkgo biloba to healthy young volunteers. Pharmacol Biochem Behav 59: 527-535.
15. Herry C, Garcia R (2002). Prefrontal cortex long-term potentiation but not long-term depression, is associated with the maintenance of extinction of learned fear in mice. J Neurosci 22: 577-583.
16. Herry C, Garcia R (2003). Behavioral and paired-pulse facilitation analyses of long-lasting depression at excitatory synapses in the medial prefrontal cortex in mice. Behav Brain Res 146: 89-96.
17. Hugues S, Deschaux O, Garcia R (2004). Postextinction infusion of a mitogen-activated protein kinase inhibitor into the medial prefrontal cortex impairs memory of the extinction of conditioned fear. Learn Mem 11: 540-543.
18. Krieglstein J, Ausmeier F, Ei-Abhar H, Lippert K, Welsch JM, Rupalla K (1995). Neuroprotective effects of Ginkgo biloba constituents. Eur J Pharm Sci 3: 9-48.
19. Krieglstein J, Beck T, Seibert A (1986). Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci 39: 2327-2334.
20. Landes P (1997). Market report: Whole Food magzine's 2nd annual herb market survey for U.S. health food stores. Herbal Gram 40: 52.
21. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF (1997). A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 278: 1327-1332.
22. Le Bars PL, Koeser M, Itil KZ (2000). A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb761 in dementia. Dementia Geriatr Cognit Disord 11: 230-237.
23. Lebrón K, Milad MR, Quirk GJ (2004). Delayed recall of fear extinction in rats with lesions of ventral medial prefrontal cortex. Learn Mem 11: 544-548.
24. Ledgerwood L, Richardson R, Cranney J (2003). Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci 117: 341-349.
25. Ledgerwood L, Richardson R, Cranney J (2004). D-cycloserine and the facilitation of extinction of conditioned fear. Consequences for reinstatement. Behav Neurosci 118: 505-513.
26. Lin CH, Yeh SH, Leu TH, Chang WC, Wang ST, Gean PW (2003a). Identification of calcineurin as a key signal in the extinction of fear memory. J Neurosci 23: 1574-1579.
27. Lin CH, Yeh SH, Lu HY, Gean PW (2003b). The similarities and diversities of signal pathways leading to condolidation of conditioning and condsolidation of extinction of fear memory. J Neurosci 23: 8310-8317.
28. Lu KT, Walker DL, Davis M (2001). Mitogen-activated protein kinase cascade in the basolateral nucleus of amygdala is involved in extinction of fear-potentiated startle. J Neurosci 21: RC162:1-5.
29. Milad MR, Quirk GJ (2002). Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420: 70-74.
30. Millan SJ, Gacia de la Asuncion J, Pallardo JG, O'Conner E, Martin J, Droy-Lefaiz MT et al (1998). A Ginkgo biloba extract (EGb761) prevents mitochondrial aging by protecting against oxidative stress. Free Radical Biol Med 24: 298-304.
31. Myers KM, Davis M (2002). Behavioral and neural analysis of extinction. Neuron 36: 567-584.
32. O'Hara M, Kiefer D, Farrell K, Kemper K (1998). A review of 12 commonly used medicinal herbs. Arch Fam Med 7: 523-536.
33. Paxinos G, Watson C (1997). The Rat Brain in Stereotaxic Coordinates, 3rd edn. Academic: New York.
34. Porsolt RD, Martin P, Lenegre A, Fromage S, Drieu K (1990). Effects of an extract of Ginkgo biloba (EGb761) on 'learned helplessness' and other models of stress in rodents. Pharmacol Biochem Behav 36: 963-971.
35. Quirk GJ, Russo GK, Barron JL, Lebrón K (2000). The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci 20: 6225-6231.
36. Santini E, Ge H, Ren K, de Ortiz SP, Quirk GJ (2004). Consolidation of fear extinction requires protein synthesis in the medial prefrontal cortex. J Neurosci 24: 5704-5710.
37. Siddiqui MF, Levey AI (1999). Cholinergic therapies in Alzheimer's disease. Drug Future 24: 417-444.
38. Szapiro G, Vianna MR, McGaugh JL, Medina JH, Izquierdo I (2003). The role of NMDA glutamate receptors, PKA, MAPK, and CAMKII in the hippocampus in extinction of conditioned fear. Hippocampus 13: 53-58.
39. Taylor JE (1992). In vitro interactions of EGb 761 with biogenic amine uptake sites and NMDA receptors. In: Christen Y, Costintin J, Lacour M (eds). Effects of Ginkgo biloba Extract (EGb 761) on the Central Nervous System. Elservier: Paris. pp 41-46.
40. Van Dongen MC, Van Rossum E, Kessels AG, Sielhorst HJ, Knipschild PG (2000). The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc 48: 1183-1194.
41. Vienna MR, Szapiro G, McGaugh JL, Medina JH, Izquierdo I (2001). Retrieval of memory for fear-motivated training initates extinction requiring protein synthesis in the rat hippocampus. Proc Natl Acad Sci 98: 12251-12254.
42. Walker DL, Ressler KJ, Lu KT, Davis M (2002). Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 22: 2343-2351.
43. Ward CP, Redd K, Williams BM, Caler JR, Luo Y, McCoy JG (2002). Ginkgo biloba extract: cognitive enhancer or antistress buffer. Pharmacol Biochem Behav 72: 913-922.
44. Yang YL, Lu KT (2005). Facilitation of conditioned fear extinction by D-cycloserine is mediated by mitogen activated protein kinase and PI-3 kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala. Neuroscience 134: 247-260.
45. Yang YL, Chao PK, Lu KT (2005b). Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear. Neuropsychopharmacology, (advance online publication, 5 October 2005; doi:10.1038/ sj.npp.1300899.)
46. Yang YL, Su YW, Ng MC, Chang CL, Lu KT (2005a). Extract of Ginkgo biloba EGb 761 facilitates fear conditioning measured by fear-potentiated startle. Neurosci Lett 383: 145-150.